Opioid Analgesia in Acute Myocardial Infarction: Pharmacological Rationale, P2Y12 Inhibitor Interactions and Contemporary Clinical Interpretation

English (OpenAlex)

Opioid analgesics, particularly morphine and fentanyl, remain used in acute myocardial infarction (AMI) to relieve severe ischaemic pain and attenuate pain-driven sympathetic activation. Their role has become more complex in contemporary reperfusion care because μ-opioid receptor activation in the enteric nervous system reduces gastrointestinal motility, delays gastric emptying, and impairs the absorption of orally administered P2Y12 inhibitors. This interaction reduces early systemic exposure to clopidogrel, prasugrel, and ticagrelor, delays the onset of platelet inhibition and may prolong high residual platelet reactivity during peri-primary percutaneous coronary intervention (PCI). Randomised pharmacokinetic and pharmacodynamic studies consistently support this mechanism, and fentanyl data suggest a class-related gastrointestinal effect rather than a morphine-specific interaction. In contrast, clinical outcome evidence remains uncertain. Observational studies and registry analyses have reported adverse signals, including associations with impaired reperfusion, recurrent ischemic events, and mortality; however, interpretation is limited by confounding by indication, because opioid-treated patients often have greater pain burden, infarct severity, haemodynamic instability, vomiting or delayed reperfusion. Current evidence therefore supports neither routine opioid administration nor complete opioid avoidance. A more defensible approach is opioid management: reserving opioids for persistent moderate to severe ischemic pain, using the lowest effective dose, confirming oral P2Y12 loading dose retention and considering formulation modification, antiemetic support or intravenous antiplatelet bridging in selected high-risk patients. Effective implementation of this framework in time-critical reperfusion care requires multidisciplinary coordination among physicians, nurses, and pharmacists.